SCARSI, Mirko
 Distribuzione geografica
Continente #
EU - Europa 1.779
NA - Nord America 1.122
AS - Asia 217
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 3
AF - Africa 1
OC - Oceania 1
Totale 3.127
Nazione #
IT - Italia 1.193
US - Stati Uniti d'America 1.118
CN - Cina 190
DE - Germania 162
UA - Ucraina 161
FR - Francia 74
FI - Finlandia 56
GB - Regno Unito 48
IE - Irlanda 26
RU - Federazione Russa 21
IN - India 17
SE - Svezia 14
ES - Italia 7
BE - Belgio 6
CA - Canada 4
EU - Europa 4
RO - Romania 4
CH - Svizzera 3
BR - Brasile 2
JO - Giordania 2
JP - Giappone 2
SK - Slovacchia (Repubblica Slovacca) 2
TR - Turchia 2
AR - Argentina 1
AU - Australia 1
ID - Indonesia 1
IQ - Iraq 1
LU - Lussemburgo 1
MU - Mauritius 1
PL - Polonia 1
SG - Singapore 1
TW - Taiwan 1
Totale 3.127
Città #
Fairfield 128
Jacksonville 119
Woodbridge 115
Ann Arbor 105
Ashburn 73
Milan 72
Houston 65
Chandler 61
Wilmington 58
Beijing 56
Rome 56
Cambridge 50
Princeton 50
Nanjing 40
Seattle 39
Helsinki 36
Dublin 25
Brescia 17
Nanchang 17
Florence 15
Turin 15
Bologna 14
Des Moines 14
Dearborn 13
Mumbai 13
Torino 12
Hebei 9
Padova 9
Shenyang 9
Changsha 8
Genoa 8
Reggio Nell'emilia 8
Tianjin 8
Verona 8
Jinan 7
Modena 7
Trento 7
Venice 7
Brussels 6
Genova 6
Jiaxing 6
Nürnberg 6
San Diego 6
Boardman 5
Duino-Aurisina 5
Ferrara 5
London 5
Perugia 5
Bari 4
Capua 4
Castelnuovo Rangone 4
Catania 4
Cernobbio 4
Cisano Bergamasco 4
Dallas 4
Fermo 4
Kunming 4
Lanzhou 4
Ningbo 4
Palermo 4
Pescara 4
Quart 4
Stra 4
Trieste 4
Altopascio 3
Arcos De La Frontera 3
Bergamo 3
Cagliari 3
Camastra 3
Castel di Lama 3
Cosenza 3
Crotone 3
Desenzano del Garda 3
Ferentino 3
Haikou 3
Lecco 3
Mountain View 3
Napoli 3
Sagrado 3
Sassari 3
Scandicci 3
Udine 3
Varallo Pombia 3
Viterbo 3
Acireale 2
Albenga 2
Amman 2
Argenta 2
Argenteuil 2
Aversa 2
Calolziocorte 2
Campobasso 2
Carrara 2
Caserta 2
Casteltermini 2
Castiglione 2
Changchun 2
Copparo 2
Cumignano sul Naviglio 2
Desio 2
Totale 1.584
Nome #
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.340
Microvascular Density and Circulating Endothelial Progenitor Cells Before and After Treatment with Incretin Mimetics in Diabetic Patients 146
Relationship Between Different Subpopulations of Circulating CD4+ T-lymphocytes and Microvascular Structural Alterations in Humans 106
Type I interferons in systemic autoimmunity. 99
Impact of in utero environment on the offspring of lupus patients 96
Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis. 95
Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritis 95
Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans 94
Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases. 91
LA PREDITTIVITA DEGLI ANTICORPI ANTI-RO/SSA-P200 NEL BLOCCO CARDIACO CONGENITO 83
WINTER LUPUS FLARES ARE ASSOCIATED WITH LOWER VITAMIN D LEVELS IN A RETROSPECTIVE LONGITUDINAL STUDY OF ITALIAN PATIENTS 74
THE EFFECTS ON T-CELL IMMUNE PHENOTYPE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS TREATED WITH TWO DIFFERENT REGIMENS OF VITAMIN D SUPPLEMENTATION 73
DECREASED TITER OF ANTI-CCP ANTIBODIES AND RHEUMATOID FACTOR AND REDUCTION OF POSTSWITCH MEMORY B CELLS AFTER ABATACEPT TREATMENT FOR RHEUMATOID ARTHRITIS 73
RELATIONSHIP BETWEEN MICROVASCULAR T REGULATORY LYMPHOCYTES AND CIRCULATING LYMPHOCYTES 72
Circulating follicular helper T cells (CD4+CXCR5+ICOS+) decrease in patients with rheumatoid arthritis treated with abatacept 72
The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al 64
Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phase 63
Why not to use colchicine in COVID-19? An oldanti-inflammatory drug for a novel auto-inflammatory disease 62
Pregnancy in systemic sclerosis: a prospective study 56
REDUCTION OF PERIPHERAL BLOOD G-IFN AND IL-17 PRODUCING T CELLS AFTER THERAPY WITH ABATACEPT FOR RHEUMATOID ARTHRITIS 56
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome 52
Intravenous immunoglobulin in pregnancy: a chance for patients with an autoimmune disease. 50
REDUCTION OF T-CELL CLONAL EXPANSION IN RHEUMATOID ARTHRITIS PATIENTS AFTER 12 MONTHS OF ABATACEPT TREATMENT. 47
LOW NUMBERS OF CIRCULATING CD28 NEGATIVE T CELLS MAY BE A PREDICTIVE FACTOR OF A GOOD CLINICAL RESPONSE TO ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS 45
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 43
LA RIDUZIONE DEL NUMERO ASSOLUTO DELLE CELLULE T CD8+CD28- CIRCOLANTI ENTRO 6 MESI DI TERAPIA CON ABATACEPT COME FATTORE PREDDITIVO DI BUONA RISPOSTA CLINICA A 1 ANNO 38
Treatment with COLchicine in hospitalized patients affected by COVID-19: The COLVID-19 trial 10
Totale 3.195
Categoria #
all - tutte 8.090
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.090


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019291 0 0 0 0 0 25 35 53 25 31 58 64
2019/2020704 102 32 37 65 40 79 65 69 35 105 34 41
2020/2021606 24 75 49 79 19 64 31 56 63 64 59 23
2021/2022484 22 47 13 40 20 63 40 44 34 52 48 61
2022/2023399 46 10 16 24 38 68 13 38 68 16 36 26
2023/2024123 21 10 26 36 24 6 0 0 0 0 0 0
Totale 3.195